Myasthenia Gravis: Epidemiology Forecast to 2028

Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Myasthenia Gravis: Executive Summary
2.1 Related Reports
2.2 Upcoming Reports
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.4 Forecast Methodology
3.4.1 Sources
3.4.2 Forecast Assumptions and Methods
3.4.3 Forecast Assumptions and Methods - Diagnosed Prevalent Cases of MG
3.4.4 Forecast Assumptions and Methods - Diagnosed Prevalent Cases of MG by Severity
3.5 Epidemiological Forecast for MG (2018-2028)
3.5.1 Diagnosed Prevalent Cases of MG
3.5.2 Age-Specific Diagnosed Prevalent Cases of MG
3.5.3 Sex-Specific Diagnosed Prevalent Cases of MG
3.5.4 Diagnosed Prevalent Cases of MG by Severity
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 Limitations of the Analysis
3.6.3 Strengths of the Analysis
4 Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologists
4.2.2 Reviewers
4.2.3 Global Director of Therapy Analysis and Epidemiology
4.2.4 Global Head and EVP of Healthcare Operations and Strategy
4.3 About GlobalData
4.4 Contact Us
4.5 Disclaimer

List of Tables
Table 1: Risk Factors and Comorbidities for MG

List of Figures
Figure 1: 7MM, Diagnosed Prevalent Cases of MG, N, Both Sexes, All Ages, 2018 and 2028
Figure 2: 7MM, Diagnosed Prevalence of MG, %, Both Sexes, All Ages, 2018
Figure 3: 7MM, Sources Used and Not Used to Forecast the Diagnosed Prevalent Cases of MG
Figure 4: 7MM, Sources Used to Forecast the Diagnosed Prevalent Cases of MG by Severity
Figure 5: 7MM, Diagnosed Prevalent Cases of MG, N, Both Sexes, All Ages, 2018
Figure 6: 7MM, Age-Specific Diagnosed Prevalent Cases of MG, N, Both Sexes, All Ages, 2018
Figure 7: 7MM, Sex-Specific Diagnosed Prevalent Cases of MG, N, All Ages, 2018
Figure 8: 7MM, Diagnosed Prevalent Cases of MG by Severity, N, Both Sexes, All Ages, 2018